The Growth and Impact of Alzheimer Disease Centers as Measured by Social Network Analysis
Open Access
- 1 April 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 71 (4) , 412-420
Abstract
Alzheimer disease (AD) is a neurodegenerative disorder that is the leading cause of dementia in people aged 65 years or older. At present, there is no cure and there are no survivors; all AD cases end in death. More than 5 million Americans have AD, and it recently passed diabetes mellitus to become the sixth leading cause of death in the United States.1 Worldwide, more than 35 million people live with AD and related dementias, ultimately resulting in costs exceeding $600 billion.2 To put this number in perspective, approximately 1% of the world’s gross domestic product is used to care for patients with AD and related forms of dementia.2Keywords
This publication has 24 references indexed in Scilit:
- The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inceptionAlzheimer's & Dementia, 2013
- Monetary Costs of Dementia in the United StatesNew England Journal of Medicine, 2013
- Network InterventionsScience, 2012
- Does Collocation Inform the Impact of Collaboration?PLOS ONE, 2010
- Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plansAlzheimer's & Dementia, 2010
- The Alzheimer's Disease Centers' Uniform Data Set (UDS)Alzheimer Disease & Associated Disorders, 2009
- Alzheimer’s Disease Research: Scientific Productivity and Impact of the Top 100 Investigators in the FieldJournal of Alzheimer’s Disease, 2009
- The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease CentersAlzheimer Disease & Associated Disorders, 2006
- Public funding for Alzheimer disease research in the United StatesNature Medicine, 2006
- An index to quantify an individual's scientific research outputProceedings of the National Academy of Sciences, 2005